This is the authors' abstract. We don't add key points for this paper.
Our data confirms the significant heterogeneity of retrorectal tumors, which poses a challenge to management, especially considering the often nonspecific symptoms. Regarding diagnosis and treatment, our data highlights the importance of MRI and surgical resection. In particular a malignancy rate of almost 20% warrants a surgical resection in case of the findings of a retrorectal tumour. A local recurrence rate of 19% supports the need for follow up.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fechner et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: